Neuromuscular complications of immune checkpoint inhibitors.
Presse Med
; 47(11-12 Pt 2): e253-e259, 2018.
Article
in En
| MEDLINE
| ID: mdl-30413332
ABSTRACT
Immune checkpoint inhibitors have been increasingly used in patients with various cancers. Despite favourable oncological outcomes these treatments have also been associated with immune-related adverse events. Neurological irAE are rare but potentially severe and neuromuscular complications are the most common. This is a new group of neurologic complications of systemic anticancer therapies, often responsive to immune-modulating therapies. Early recognition and treatment are crucial for timely improvement of functional outcome and requires a multidisciplinary approach.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Kinase Inhibitors
/
Immunotherapy
/
Neoplasms
/
Neuromuscular Diseases
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Presse Med
Year:
2018
Document type:
Article